Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

5 results
Display

Pseudomembranous Colitis after 5-fluorouracil Chemotherapy in Rectal Cancer Patient

Cheon SH, Kim KH

  • KMID: 772852
  • Korean J Gastroenterol.
  • 2005 Nov;46(5):319-320.
No abstract availble
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Gemcitabine-Induced Hemolytic Uremic Syndrome in Pancreatic Cancer: A Case Report and Review of the Literature

Lee HW, Chung MJ, Kang H, Choi H, Choi YJ, Lee KJ, Lee SW, Han SH, Kim JS, Song SY

  • KMID: 1774536
  • Gut Liver.
  • 2014 Jan;8(1):109-112.
Hemolytic uremic syndrome (HUS) is a rare thrombotic complication characterized by a triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. HUS may be caused by several different conditions,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Therapy-Related Acute Myeloid Leukemia Following 5-Fluorouracil Chemotherapy

Park HJ, Choi JH, Lee KA, Kim HC, Nam YS, Oh YH, Lee WS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Wernicke's Encephalopathy Following Fluorouracil-based Chemotherapy

Cho IJ, Chang HJ, Lee KE, Won HS, Choi MY, Nam EM, Mun YC, Lee SN, Seong CM

The pyrimidine antimetabolite 5-fluorouracil (5-FU) is a chemotherapeutic agent used widely for various tumors. Common side effects of 5-FU are related to its effects on the bone marrow and gastrointestinal...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Unpredicted Severe Toxicity after 5-Fluorouracil Treatment due to Dihydropyrimidine Dehydrogenase Deficiency

Baek JH, Kim JG, Kim SN, Kim DH, Sohn SK, Hong YJ, Lee KB

Dihydropyrimidine dehydrogenase (DPD) is the initial and rate-limiting enzyme in the catabolism of 5-fluorouracil (5-FU). Thus, patients with a DPD deficiency are at risk of developing severe 5-FU-associated toxicity. A...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr